The European Commission and WHO extend their strategic cooperation to deliver better health for all
The European Commission and WHO extend their strategic cooperation to deliver better health for all At the EU-WHO Strategic Dialogue…
Read More
New report showcases strategies to keep children safe online
New report showcases strategies to keep children safe online A new report published today by the World Health Organization (WHO), What…
Nanotech strategy shows promise for treating autoimmune disease
Nanotech strategy shows promise for treating autoimmune disease Scientists at Scripps Research have reported success in initial tests of a…
ANNOUNCEMENT FOR THE PURPOSES OF RULE 2.12 OF THE IRISH TAKEOVER PANEL ACT
ANNOUNCEMENT FOR THE PURPOSES OF RULE 2.12 OF THE IRISH TAKEOVER PANEL ACT Further to the announcement made by Horizon…
AMGEN PRESENTS NEW AMG 133 PHASE 1 CLINICAL DATA AT WCIRDC 2022
AMGEN PRESENTS NEW AMG 133 PHASE 1 CLINICAL DATA AT WCIRDC 2022 Amgen (NASDAQ:AMGN) today announced new Phase 1 data from…
Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases
Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases Eli Lilly and Company (NYSE: LLY) announced the…
Sanofi to showcase new data from oncology portfolio spanning marketed products and investigational compounds at ASH 2022
Sanofi to showcase new data from oncology portfolio spanning marketed products and investigational compounds at ASH 2022 Data featured at…
Merck to Present Data From Its Hematology Portfolio and Promising Pipeline at the 64th American Society of Hematology (ASH) Annual Meeting
Merck to Present Data From Its Hematology Portfolio and Promising Pipeline at the 64th American Society of Hematology (ASH) Annual…
Jemperli (dostarlimab) RUBY phase III trial met its primary endpoint in a planned interim analysis in patients with primary advanced or recurrent endometrial cancer
Jemperli (dostarlimab) RUBY phase III trial met its primary endpoint in a planned interim analysis in patients with primary advanced…
European Medicines Agency accepts marketing authorization application for momelotinib for the treatment of myelofibrosis
European Medicines Agency accepts marketing authorization application for momelotinib for the treatment of myelofibrosis GSK plc (LSE/NYSE: GSK) announced that…
Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate
Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate Pfizer Inc. (NYSE:…
WHO calls on the global community to equalize the HIV response
WHO calls on the global community to equalize the HIV response On 1 December, World AIDS Day 2022, the World…